ArticleThe Kaohsiung journal of medical sciences2021

Reduced serum miR-202 may promote the progression of Alzheimer's disease patients via targeting amyloid precursor protein.

Li-Hua Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.